1. Medtech Insight
  2. >>Geography
  3. >>Asia

Singapore To Make Major Medtech Regulatory Changes Under Economic Growth Plan

 
• By Ashley Yeo

Regulatory and market access improvements for medtech products were on the agenda at last month's Health Products Regulatory Forum in Singapore. These forward-looking changes are seen by the government and the Health Sciences Authority (HSA) as the medtech sector's contribution to initiatives and aims developed by the Singapore Committee on the Future Economy (CFE).

Singapore Garden Bay

Significant medtech regulatory reforms are the works in Singapore based on work of the country's Committee on the Future Economy (CFE). A report issued by the CFE in February included recommendations impacting all sectors of the national economy, including multiple medtech regulatory reforms.

Medtech industry stakeholders convened May 18-19 at the Health Products Regulatory Forum in Singapore to talk about the device industry's contributions to the country's economy and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Asia

Medical Devices Not The Focus Of FDA’s Plans To Step Up Foreign Inspections, Expert Says

 
• By Brian Bossetta

The US FDA recently announced plans to carry out more unannounced inspections of foreign facilities. But those inspections will primarily target drug producers, with less attention and resources allocated to those making devices.

Consumer Healthtech Investment Totaled $4.5BN In 2024, But Bar Is High Amid Economic Uncertainty

 
• By Marion Webb

Global investment in consumer healthtech increased by 9% year-over-year in 2024, totaling $4.5bn, with significant interest in mental health solutions, according to Galen Growth. While the first quarter of 2025 saw raised confidence and investments, the Trump administration’s new tariffs and sweeping changes to healthcare have introduced new uncertainties.

Don’t Sleep On Inspections: Experts Warn FDA Maintains Enforcement Resources

 
• By Brian Bossetta

Manufacturers of medical products would be foolish to think that recent upheavals at the US FDA will result in a lack of inspections in the coming years. A panel of experts discussed the current state of inspections during a webinar hosted by the Food and Drug Law Institute.

South Korea Adds Digital Health Rules To Already Complicated Regulatory Landscape

 
• By Elizabeth Orr

A New South Korean law, the Digital Medical Products Act, enhances regulation for digital health products. Medical devices in the country are categorized both by risk and by similarity to already authorized devices. The approval process may stretch to 515 days for new manufacturers.

More from Geography